Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT06343311

Conditions: B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
Locations: University of California, Davis Sacramento, California, United States

Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States

View Trial Details

Recruiting

A Phase I Dose Finding Study of MB-CART2219.1

NCT07108868

Conditions: Acute Lymphoblastic Leukemia, Pediatric, CLL, Hematologic Diseases, +11 more
Locations: University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany

University Hospital, Clinic for Pediatric Medicine Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Recruiting

Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)

NCT05444348

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +20 more
Locations: Aalborg Universitetshospital Aalborg, Denmark

Aarhus Universitetshospital Aarhus, Denmark

Sydvestjysk sygehus - Esbjerg Esbjerg, Denmark

Regionshospitalet Gødstrup Herning, Denmark

View Trial Details

Recruiting

Mediastinal EBUS Cryobiopsy Study In Sweden

NCT06347939

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +23 more
Locations: Respiratory medicine and allergy department, Skåne University Hospital Lund, Sweden

Norrlands universitetssjukhus Umeå, Sweden

View Trial Details

Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

NCT04053439

Conditions: Chemotherapeutic Toxicity, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer

NCT04827810

Conditions: Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

NCT05618041

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Shanxi Bethune Hospital Taiyuan, Shanxi, China

View Trial Details

Recruiting

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV

NCT07032103

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Recruiting

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

NCT06550427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions